» Articles » PMID: 17898072

Crimean-Congo Hemorrhagic Fever Virus Glycoprotein Processing by the Endoprotease SKI-1/S1P is Critical for Virus Infectivity

Overview
Journal J Virol
Date 2007 Sep 28
PMID 17898072
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Crimean-Congo hemorrhagic fever virus (CCHFV) causes severe human disease. The CCHFV medium RNA encodes a polyprotein which is proteolytically processed to yield the glycoprotein precursors PreGn and PreGc, followed by structural glycoproteins Gn and Gc. Subtilisin kexin isozyme-1/site-1 protease (SKI-1/S1P) plays a central role in Gn processing. Here we show that CCHFV-infected cells deficient in SKI-1/S1P produce no infectious virus, although PreGn and PreGc accumulated normally in the Golgi apparatus, the site of virus assembly. Only nucleoprotein-containing particles which lacked virus glycoproteins (Gn/Gc or PreGn/PreGc) were secreted. Complementation of SKI-1/S1P-deficient cells with a SKI-1/S1P expression vector restored release of infectious virus (>10(6) PFU/ml), confirming that SKI-1/S1P processing is required for incorporation of viral glycoproteins. SKI-1/S1P may represent a promising antiviral target.

Citing Articles

Crimean Congo hemorrhagic fever virus nucleoprotein and GP38 subunit vaccine combination prevents morbidity in mice.

Karaaslan E, Sorvillo T, Scholte F, ONeal T, Welch S, Davies K NPJ Vaccines. 2024; 9(1):148.

PMID: 39143104 PMC: 11324950. DOI: 10.1038/s41541-024-00931-y.


Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spread.

Pahmeier F, Monticelli S, Feng X, Hjorth C, Wang A, Kuehne A bioRxiv. 2024; .

PMID: 38826290 PMC: 11142176. DOI: 10.1101/2024.05.23.595578.


A replicating RNA vaccine confers protection in a rhesus macaque model of Crimean-Congo hemorrhagic fever.

Hawman D, Leventhal S, Meade-White K, Khandhar A, Murray J, Lovaglio J NPJ Vaccines. 2024; 9(1):86.

PMID: 38769294 PMC: 11106275. DOI: 10.1038/s41541-024-00887-z.


Evaluation of two inoculation routes of an adenovirus-mediated viral protein inhibitor in a Crimean-Congo hemorrhagic fever mouse model.

Scholte F, Spengler J, Welch S, Harmon J, Coleman-McCray J, Davies K Virus Res. 2024; 345:199398.

PMID: 38754786 PMC: 11137588. DOI: 10.1016/j.virusres.2024.199398.


Establishment of two serological methods for detecting IgG and neutralizing antibodies against Crimean-Congo hemorrhagic fever virus glycoprotein.

Wang Q, Wang S, Shi Z, Li Z, Zhao Y, Feng N Front Cell Infect Microbiol. 2024; 14:1341332.

PMID: 38746783 PMC: 11091404. DOI: 10.3389/fcimb.2024.1341332.


References
1.
Gerrard S, Nichol S . Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins. Virology. 2006; 357(2):124-33. PMC: 7172627. DOI: 10.1016/j.virol.2006.08.002. View

2.
Ergonul O . Crimean-Congo haemorrhagic fever. Lancet Infect Dis. 2006; 6(4):203-14. PMC: 7185836. DOI: 10.1016/S1473-3099(06)70435-2. View

3.
Altamura L, Bertolotti-Ciarlet A, Teigler J, Paragas J, Schmaljohn C, Doms R . Identification of a novel C-terminal cleavage of Crimean-Congo hemorrhagic fever virus PreGN that leads to generation of an NSM protein. J Virol. 2007; 81(12):6632-42. PMC: 1900101. DOI: 10.1128/JVI.02730-06. View

4.
Ye J, Rawson R, Komuro R, Chen X, Dave U, Prywes R . ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol Cell. 2001; 6(6):1355-64. DOI: 10.1016/s1097-2765(00)00133-7. View

5.
Lenz O, ter Meulen J, Klenk H, Seidah N, Garten W . The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P. Proc Natl Acad Sci U S A. 2001; 98(22):12701-5. PMC: 60117. DOI: 10.1073/pnas.221447598. View